An Oxford team built a RecBCD enzyme assay in three weeks using Synthace automated DOE.
The team needed a biochemical assay for the DNA-repair enzyme RecBCD without slow one-variable-at-a-time optimisation, and had no prior assay experience. Using Synthace they designed and ran two automated DOE experiments covering 10 factors. The page reports a three-week timeline including validation, a z' of 0.59 (n=128), and identified optimal MgCl2:ATP ratios.
Synthace is a software company whose design-of-experiments and lab automation platform helps biology teams develop and transfer assays faster.
This sits in the Design & Stress-Test stage of the AI use-case lifecycle: Named examples from the tools pharma teams use to scope, prototype and benchmark an AI use case before committing to build it — data-catalog, sandbox and evaluation platforms.
Published by Synthace on its own site — read the original case study on synthace.com ↗
Related use cases
- 01Charles River used Synthace DOE software to miniaturise and transfer a SARS-CoV-2 protease assay to 1536-well plates.
- 02Novo Nordisk Transforms Clinical Trials With AI
- 03How Regeneron is discovering new treatments with AI
- 04How AI is changing drug discovery
- 05Bayer transforms global data management with Databricks
- 06Delivering timely insights that drive better patient care